JPY 1327.0
(1.3%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 29.84 Billion JPY | 12.91% |
2022 | 26.42 Billion JPY | 12.94% |
2021 | 23.4 Billion JPY | 19.41% |
2020 | 19.59 Billion JPY | 24.58% |
2019 | 15.73 Billion JPY | 13.56% |
2018 | 13.85 Billion JPY | 18.59% |
2017 | 11.68 Billion JPY | 21.14% |
2016 | 9.64 Billion JPY | 14.81% |
2015 | 8.39 Billion JPY | 15.43% |
2014 | 7.27 Billion JPY | 12.67% |
2013 | 6.45 Billion JPY | 22.1% |
2012 | 5.28 Billion JPY | 21.67% |
2011 | 4.34 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 7.88 Billion JPY | -3.64% |
2023 FY | 29.84 Billion JPY | 12.91% |
2023 Q3 | 7.32 Billion JPY | 2.16% |
2023 Q1 | 7.17 Billion JPY | -1.64% |
2023 Q2 | 7.16 Billion JPY | -0.15% |
2023 Q4 | 8.17 Billion JPY | 11.73% |
2022 Q4 | 7.29 Billion JPY | 12.44% |
2022 FY | 26.42 Billion JPY | 12.94% |
2022 Q3 | 6.48 Billion JPY | -1.17% |
2022 Q2 | 6.56 Billion JPY | 8.01% |
2022 Q1 | 6.07 Billion JPY | -2.89% |
2021 FY | 23.4 Billion JPY | 19.41% |
2021 Q2 | 6.09 Billion JPY | 13.45% |
2021 Q4 | 6.25 Billion JPY | 10.49% |
2021 Q1 | 5.37 Billion JPY | -12.87% |
2021 Q3 | 5.66 Billion JPY | -7.12% |
2020 Q1 | 3.83 Billion JPY | -9.59% |
2020 Q2 | 4.53 Billion JPY | 18.23% |
2020 FY | 19.59 Billion JPY | 24.58% |
2020 Q3 | 5.05 Billion JPY | 11.43% |
2020 Q4 | 6.17 Billion JPY | 22.08% |
2019 Q1 | 3.77 Billion JPY | -8.12% |
2019 FY | 15.73 Billion JPY | 13.56% |
2019 Q2 | 3.93 Billion JPY | 4.38% |
2019 Q4 | 4.24 Billion JPY | 12.4% |
2019 Q3 | 3.77 Billion JPY | -4.14% |
2018 Q4 | 4.1 Billion JPY | 25.51% |
2018 Q2 | 3.18 Billion JPY | -2.87% |
2018 Q1 | 3.28 Billion JPY | -3.66% |
2018 FY | 13.85 Billion JPY | 18.59% |
2018 Q3 | 3.27 Billion JPY | 2.59% |
2017 Q3 | 2.89 Billion JPY | 8.46% |
2017 FY | 11.68 Billion JPY | 21.14% |
2017 Q1 | 2.7 Billion JPY | -4.74% |
2017 Q4 | 3.4 Billion JPY | 17.75% |
2017 Q2 | 2.66 Billion JPY | -1.46% |
2016 Q4 | 2.84 Billion JPY | 31.23% |
2016 FY | 9.64 Billion JPY | 14.81% |
2016 Q3 | 2.16 Billion JPY | -5.83% |
2016 Q2 | 2.3 Billion JPY | -1.31% |
2016 Q1 | 2.33 Billion JPY | -3.51% |
2015 Q2 | 2.13 Billion JPY | 6.95% |
2015 Q4 | 2.41 Billion JPY | 30.21% |
2015 Q3 | 1.85 Billion JPY | -13.0% |
2015 FY | 8.39 Billion JPY | 15.43% |
2015 Q1 | 1.99 Billion JPY | -3.28% |
2014 FY | 7.27 Billion JPY | 12.67% |
2014 Q4 | 2.06 Billion JPY | 21.3% |
2014 Q3 | 1.69 Billion JPY | -7.83% |
2014 Q2 | 1.84 Billion JPY | 10.42% |
2014 Q1 | 1.67 Billion JPY | -12.47% |
2013 Q1 | 1.52 Billion JPY | -0.32% |
2013 Q3 | 1.46 Billion JPY | -5.32% |
2013 Q4 | 1.9 Billion JPY | 29.91% |
2013 FY | 6.45 Billion JPY | 22.1% |
2013 Q2 | 1.55 Billion JPY | 1.39% |
2012 FY | 5.28 Billion JPY | 21.67% |
2012 Q2 | 1.26 Billion JPY | 0.0% |
2012 Q3 | 1.22 Billion JPY | -3.44% |
2012 Q4 | 1.53 Billion JPY | 25.6% |
2011 FY | 4.34 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Kitanotatsujin Corporation | 14.66 Billion JPY | -103.472% |
Euglena Co., Ltd. | 44.39 Billion JPY | 32.779% |
Axas Holdings Co.,Ltd. | 11.71 Billion JPY | -154.643% |
C.I. Medical Co.,Ltd. | 45.62 Billion JPY | 34.6% |
Kao Corporation | 1532.57 Billion JPY | 98.053% |
Niitaka Co., Ltd. | 22.73 Billion JPY | -31.232% |
Rohto Pharmaceutical Co.,Ltd. | 270.84 Billion JPY | 88.982% |
Shiseido Company, Limited | 973.03 Billion JPY | 96.933% |
Lion Corporation | 402.76 Billion JPY | 92.591% |
Mandom Corporation | 73.23 Billion JPY | 59.252% |
Ivy Cosmetics Corporation | 2.71 Billion JPY | -999.622% |
Milbon Co., Ltd. | 47.76 Billion JPY | 37.522% |
Nippon Shikizai, Inc. | 15.05 Billion JPY | -98.278% |
Fancl Corporation | 110.88 Billion JPY | 73.087% |
KOSÉ Corporation | 300.4 Billion JPY | 90.066% |
Cota Co., Ltd. | 9.13 Billion JPY | -226.595% |
HABA Laboratories,Inc. | 12.32 Billion JPY | -142.132% |
C'bon Cosmetics Co.,Ltd. | 8.49 Billion JPY | -251.112% |
Pola Orbis Holdings Inc. | 173.3 Billion JPY | 82.781% |
Noevir Holdings Co., Ltd. | 62.55 Billion JPY | 52.294% |
Adjuvant Holdings Co.,Ltd. | 4.43 Billion JPY | -572.362% |
Almado, Inc. | 7.53 Billion JPY | -295.832% |
I-ne CO., LTD. | 41.64 Billion JPY | 28.341% |
Premier Anti-Aging Co., Ltd. | 20.35 Billion JPY | -46.574% |
Liberta Co.,Ltd. | 7.08 Billion JPY | -321.018% |
AXXZIA Inc. | 12.19 Billion JPY | -144.75% |
S.T. Corporation | 44.47 Billion JPY | 32.9% |
Kobayashi Pharmaceutical Co., Ltd. | 173.45 Billion JPY | 82.796% |
Earth Corporation | 158.34 Billion JPY | 81.154% |
Sagami Rubber Industries Co., Ltd. | 6.11 Billion JPY | -388.189% |
Asahi Eito Holdings Co.,Ltd. | 3.51 Billion JPY | -748.298% |
Ya-Man Ltd. | 32.02 Billion JPY | 6.817% |
MTG Co., Ltd. | 60.15 Billion JPY | 50.392% |
TRANSACTION CO.,Ltd. | 25.04 Billion JPY | -19.139% |
SHOBIDO Corporation | 20.44 Billion JPY | -45.966% |
Artnature Inc. | 42.85 Billion JPY | 30.36% |
Pigeon Corporation | 94.46 Billion JPY | 68.409% |
Unicharm Corporation | 941.79 Billion JPY | 96.831% |
Paltac Corporation | 1151.96 Billion JPY | 97.41% |
CB GROUP MANAGEMENT Co., Ltd. | 147.28 Billion JPY | 79.739% |